이상반응 보고
| VAERS ID | 1397975 |
|---|---|
| 성별 | 여성 |
| 나이 | |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | EP2163 |
| 예방접종 횟수 | 2 |
| 접종일 | 2021-02-26 |
| 발병일 | 2021-03-04 |
| 상태 | 입원 사망 |
증상
- SARS-CoV-2 테스트(SARS-CoV-2 test)
- 흉부 엑스레이(Chest X-ray)
- 코로나 바이러스 감염증 -19 : 코로나 19(COVID-19)
- 폐렴(Pneumonia)
- 예방접종 실패(Vaccination failure)
이환 중 질병
지병
Medical History/Concurrent Conditions: Angiopathy; Diabetes mellitus; Diabetic nephropathy; Glaucoma; Hyperlipidemia; Hypertension; Obesity; Renal insufficiency
기타 의료
이전 예방접종
알레르기
임상 검사
Test Date: 20210304; Test Name: Chest X-ray; Result Unstructured Data: Test Result:Pneumonia; Test Date: 20210304; Test Name: COVID-19 antigen test; Test Result: Positive
증상 상세
Vaccination failure; COVID-19; Pneumonia; This is a spontaneous report downloaded from the Agency Regulatory Authority-WEB, regulatory authority number HU-OGYI-383421.
A contactable physician 83-years-old female patient received second dose of bnt162b2 (COMIRNATY, Solution for injection, Lot number: EP2163 and Expiry date: Unknown), intramuscular on 26Feb2021 as 2nd dose, 0.
3 ml single dose for covid-19 immunization.
Medical history included hypertension, diabetic nephropathy, renal failure, angiopathy, glaucoma, hyperlipidemia, diabetes mellitus, obesity from an unknown date and unknown if ongoing.
.
The patient's concomitant medications were not reported.
The patient previously took first dose of bnt162b2 (COMIRNATY, Lot Number: EJ6136), on 05Feb2021 for covid-19 immunization.
On 04Mar2021, the patient experienced pneumonia, covid-19, vaccination failure.
The patient was hospitalized on 04Feb2021, where covid-19 antigen test was positive and chest X-ray showed pneumonia.
The patient was hospitalized for pneumonia from 04Mar2021 to an unknown date.
The patient was hospitalized for covid-19 from 04Mar2021 to an unknown date.
The patient was hospitalized for vaccination failure from 04Mar2021 to an unknown date.
On 04Mar2021, the patient underwent lab tests and procedures which included chest x-ray: pneumonia, sars-cov-2 test: positive.
Therapeutic measures were taken as a result of pneumonia, covid-19, vaccination failure and treatment included.
The patient died on 06Mar2021.
An autopsy was not performed.
Sender Comment included According to the SmPC of Comirnaty, immunity usually develops 7 days after the second dose.
The patient had a positive Covid-19 antigen test 6 days after the second dose, therefore vaccination failure is considered possible.
The case is considered serious because the outcome was fatal.
Further information is not expected.
No follow-up attempts possible.
No further information expected.
; Reported Cause(s) of Death: COVID-19